Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers
about
Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)Neuraminidase inhibitors for preventing and treating influenza in childrenNeuraminidase inhibitors for influenza B virus infection: efficacy and resistanceStructural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA InhibitionDetection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in JapanJapanese Surveillance Systems and Treatment for Influenza.From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Antiviral therapy in seasonal influenza and 2009 H1N1 pandemic influenza: Korean experiences and perspectives.ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.Antivirals in seasonal and pandemic influenza--future perspectives.Newer influenza antivirals, biotherapeutics and combinations.Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infectionA cutting-edge view on the current state of antiviral drug development.Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.Optimizing antiviral therapy for influenza: understanding the evidence.Clinical pharmacokinetics of inhaled antimicrobials.Intrapulmonary distribution and pharmacokinetics of laninamivir, a neuraminidase inhibitor, after a single inhaled administration of its prodrug, laninamivir octanoate, in healthy volunteersIntrapulmonary Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Nebulized Administration of Laninamivir Octanoate in Healthy Japanese Subjects.
P2860
Q24200222-EEC2956A-6FB8-4564-9726-42A40DBAD162Q24203875-1457E260-6D5B-4204-BA4D-88DE25A1DAF8Q27021579-10E488FE-96E0-48DF-AEEF-7B24761FADB3Q27675230-4DFDAF65-E1BF-459A-AC2F-8407DCEF561BQ28545776-8CE0A090-3CB3-4230-A819-22B358D669BEQ30239895-26D569FC-B37F-4A35-8B64-848AD89D4E46Q30363724-C17C69E7-B786-4ED6-A054-2DE1A59026E5Q30377702-327D2C10-2861-4316-A4DD-80D8950C9C72Q30404586-E81C2ED5-CD3A-4B4C-B3D6-544DAED46DD5Q30407794-1DC8F765-CDE1-4A33-BAEA-493A7AF4F9C5Q30425358-4ED6BF55-3B24-4417-9E60-D733DD8CE376Q30456363-557AF99A-8369-45B4-8E0D-68DB864862E5Q33676271-ED65D3DA-FC92-4C5B-B63D-0D3DCD5FED94Q33876428-985A6627-6A76-45DA-8568-EFA1A6D227A8Q34036018-AE4E29D9-D16A-40AF-8A27-7B2F469CE5D9Q38084212-5AAA011E-0FB7-44FC-A49B-6CE908A29130Q38361244-F0692BC4-3DFE-4845-9E5C-AD828EA2C5B6Q38367260-DDA1E3A5-6FAD-4BAD-83C7-53BE04BFBEFBQ42110576-DEA5CC26-92DE-4480-8977-7FDFF3443D0BQ47603384-6EC3E77E-ECAD-4560-88B0-6C1728AA92E1
P2860
Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@ast
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@en
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@nl
type
label
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@ast
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@en
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@nl
prefLabel
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@ast
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@en
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@nl
P2093
P2860
P356
P1476
Clinical pharmacokinetics of l ...... 58, in healthy male volunteers
@en
P2093
Hiromi Okabe
Hitoshi Ishizuka
Kazutaka Yoshihara
Satoshi Yoshiba
P2860
P304
P356
10.1177/0091270009356297
P407
P577
2010-11-01T00:00:00Z